Naleway Allison L, Weinmann Sheila, Krishnarajah Girishanthy, Arondekar Bhakti, Fernandez Jovelle, Swamy Geeta, Myers Evan
The Center for Health Research, Kaiser Permanente Northwest, Portland, OR, United States of America.
GlaxoSmithKline, North American Vaccine Development, Philadelphia and King of Prussia, PA, United States of America.
PLoS One. 2015 Feb 11;10(2):e0117525. doi: 10.1371/journal.pone.0117525. eCollection 2015.
To determine whether treatments for precancerous cervical lesions were associated with lower pregnancy rates compared to rates in unexposed women and women who had a diagnostic cervical biopsy or colposcopy.
Matched, retrospective cohort study.
Kaiser Permanente Northwest (KPNW), an integrated healthcare delivery system in Oregon and Washington.
Women 14 to 53 years old with KPNW enrollment during the period 1998 through 2009.
Pregnancy after exposure or index date. Pregnancy was defined using a validated algorithm and electronic medical records data.
We observed 570 pregnancies following cervical treatment in 4,137 women, 1,533 pregnancies following a diagnostic procedure in 13,767 women, and 7,436 pregnancies in a frequency-matched sample of 81,435 women unexposed to treatment or diagnostic procedures. After adjusting for age and contraceptive use, we observed a higher rate of pregnancies in the treatment group compared to unexposed women (hazard ratio (HR) = 1.42, 95% confidence interval (CI): 1.30-1.55), but no difference in pregnancy rates between the treatment and diagnostic procedure groups (HR = 1.03, 95% CI: 0.93-1.13).
No adverse effects of cervical procedures on subsequent rates of pregnancy were observed in this cohort with up to twelve years of follow-up time.
确定与未接受治疗的女性以及接受宫颈诊断性活检或阴道镜检查的女性相比,宫颈癌前病变的治疗是否与较低的妊娠率相关。
匹配的回顾性队列研究。
凯撒永久医疗集团西北分部(KPNW),俄勒冈州和华盛顿州的一个综合医疗服务体系。
1998年至2009年期间在KPNW登记的14至53岁女性。
暴露或索引日期后的妊娠情况。妊娠通过经过验证的算法和电子病历数据进行定义。
我们观察到,4137名接受宫颈治疗的女性中有570例妊娠,13767名接受诊断性检查的女性中有1533例妊娠,以及在81435名未接受治疗或诊断性检查的频率匹配样本女性中有7436例妊娠。在调整年龄和避孕措施使用情况后,我们观察到治疗组的妊娠率高于未接受治疗的女性(风险比(HR)=1.42,95%置信区间(CI):1.30-1.55),但治疗组和诊断性检查组之间的妊娠率没有差异(HR =1.03,95%CI:0.93-1.13)。
在该队列长达12年的随访期内,未观察到宫颈治疗对后续妊娠率有不良影响。